Live Breaking News & Updates on Ovishield vaccine

Stay informed with the latest breaking news from Ovishield vaccine on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ovishield vaccine and stay connected to the pulse of your community

Can person with any allergy take COVID-19 shots? Know what experts say

Can person with any allergy take COVID-19 shots? Know what experts say - Bharat Biotech, the manufacturer of the COVID-19 vaccine said that those who have known allergies to any component of Covaxin should not take the jab.

India , Bharat , Randeep-guleria , Centers-for-disease , Serum-institute-of-india , Bharat-biotech , Niti-aayog , Serum-institute , Disease-control , Covid-19-vaccine , Llergic-reactions , Harat-biotech

Government Says No Need To Change In Covishield Dosage Interval - कोविशील्ड की खुराकों के बीच अंतराल पर बोला नीति आयोग, कहा-बदलाव को लेकर जल्दबाजी नहीं

Miscellenous India News in Hindi: नीति आयोग के सदस्य डॉ.वीके पॉल ने कहा कि उचित वैज्ञानिक अध्ययन के आधार पर इसकी समयावधि में बदलाव की आवश्यकता है।

New-delhi , Delhi , India , Iia-center , World-health-organization , Vk-paul , Iti-aayog-member-vk-paul , Ovishield-vaccine , Iscellenous-india-news , Iscellenous-india-news-in-hindi , Iscellenous-india-samachar

Bombay High Court dismisses plea seeking Z-plus security for Adar Poonawalla

The Bombay High Court denied a petition seeking Z-plus security cover for Serum Institute of India (SII) CEO Adar Poonawalla on Friday.

Mumbai , Maharashtra , India , United-kingdom , Bombay , Adar-poonawalla , Bombay-high-court , Serum-institute-of-india , Chief-executive-officer , Serum-institute , Advocate-datta-mane , Dar-poonawalla

Viridian Group organizes vaccination drive for its employees and their kin

New Delhi [India], June 5 (ANI/NewsVoir): Viridian Group in collaboration with Manipal Hospital, Dwarka organized a free vaccination drive for its employees and their family members at its Delhi located office.

Manipal , Karnataka , India , Delhi , Dwarka , Gujarat , New-delhi , Anuj-bhandari , Head-applied-research , Viridian-group , Manipal-hospital , Medical-college

Over 1.20 Crore Covid Vaccine Doses Were Supplied To Private Hospitals: Centre

The centre said a large number of private hospitals that had a contract with Serum Institute of India and Bharat Biotech have been supplied with Covishield and Covaxin doses.

India , Bharat , Centre-on , Serum-institute-of-india , Serum-institute , Bharat-biotech , Private-hospitals , Ospitals-covaxin , Ovishield-vaccine , Ovishield-hospitals , Erum-institute

COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India


COVID-19: Serum Institute applies to DCGI to manufacture Sputnik V vaccine in India
Pune-based Serum Institute has also sought approval for test analysis and examination. Sputnik V is currently being manufactured by Dr Reddy's Lab.
India's Serum Institute seeks approval from DCGI to make Russia's Sputnik V vaccine (Image Source: Reuters)
Share
Updated: Jun 3, 2021, 03:35 PM IST
Pune-based Serum Institute of India (SII), the manufacturer of the Covishield vaccine has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture COVID-19 vaccine Sputnik V in the country, government sources said on Thursday.
The Pune-based vaccine manufacturing firm has also sought approval for test analysis and examination. The SII is currently manufacturing the Covishield doses and the Novavax vaccines.

India , Hyderabad , Andhra-pradesh , Russia , Pune , Maharashtra , Stelis-biopharma , Serum-institute-of-india , Pune-based-serum-institute , Drug-controller-general , Serum-institute , Drugs-controller-general

UP man lodges complaint against SII CEO, ICMR chief; says no antibodies developed post vaccine


URL copied
UP man lodges complaint against SII CEO, ICMR chief; says no antibodies developed post vaccine
A man in Uttar Pradesh's Lucknow has filed a complaint against Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava, head of the Indian Council of Medical Research (ICMR) after he alleged that no antibodies were formed in his body after receiving the first dose of Covishield.
Pratap Chandra, a resident of Lucknow, stated that after listening to a press briefing of ICMR where it was mentioned that antibodies in sufficient quantities are formed in the body against the virus after taking the first dose, he got an antibody test to determine the level of antibodies formed in his body.

Lucknow , Uttar-pradesh , India , Rohit-sardana , Pratap-chandra , Adar-poonawala , Balram-bhargava , Union-health-ministry , Indian-council-of-medical-research , Serum-institute-of-india , Image-source , Serum-institute

'No antibodies developed despite Covishield jab': Lucknow man files case against Adar Poonawalla

Others named in the complaint are DCGA director, Joint Secretary of Health Ministry Luv Agarwal, ICMR director Balaram Bhargava, National Health Mission director Aparna Upadhyay, among others.

Lucknow , Uttar-pradesh , India , Balram-bhargav , Aparna-upadhyay , Balaram-bhargava , Pratap-chandra , Adar-poonawala , Health-ministry-luv-agarwal , Serum-institute-of-india , National-health-mission , Serum-institute